glp-1 gip news 🚨 Big for people with type 1 diabetes who are using or are interested in using a GLP-1! 35 new recommendations have been published for use of GLP-1s and GLP-1/GIP in Obesity drugs regulate neural systems

The kidney myth, the early scale bump, and the limitation no honest source can hide.

#retatrutide is a novel triple agonist peptide at the glucagon receptor, GIP receptor, and GLP-1 receptor

This breakthrough formula fires up GLP-1 production to fend off cravings, especially those carb-loaded temptations

This unique regulatory situation is contributing to a more competitive market somewhat earlier than in the U.S

This retrospective cohort study evaluated changes in time in therapeutic range (TTR) among patients receiving warfarin during the 6 months before and after GLP-1 RA initiation, using real-world data from the TriNetX Research Network

95% CI, -1.8 to -0.2 per 1000 person-years